Milvexian shows potential to reduce risk of ischemic stroke
Cardiovascular protection from statins greatly outweighs the risk of muscle symptoms
29 August 2022Study reveals mechanism involved in rare pediatric brain cancer and points to possible treatment
29 August 2022Milvexian shows potential to reduce risk of ischemic stroke
A phase 2 trial in patients with a prior ischemic stroke or high-risk transient ischemic attack (TIA) has indicated that milvexian should be further investigated for its ability to reduce the risk of ischemic stroke without a clinically important increase in bleeding. The late breaking research was presented in a Hot Line session on 28 August at ESC Congress 2022.
